XML 38 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Acquisitions (Tables)
 9 Months Ended
Sep. 30, 2018
Business Combinations [Abstract]  
Schedule of Business Acquisitions, by Acquisition
The following table summarizes the preliminary purchase price allocation for the Paragon Medical acquisition.
Fair value of assets acquired and liabilities assumed
As Reported on June 30, 2018
 
Subsequent Adjustments
 
September 30, 2018
Cash and cash equivalents
$
13,418

 
$
134

 
$
13,552

Accounts receivable
22,853

 
(721
)
 
22,132

Inventories
23,606

 
(98
)
 
23,508

Other current assets
937

 
734

 
1,671

Property, plant and equipment
69,322

 
(5,625
)
 
63,697

Intangible assets subject to amortization
164,200

 
(700
)
 
163,500

Other non-current assets
3,304

 
(129
)
 
3,175

Goodwill
157,421

 
5,017

 
162,438

Total assets acquired
$
455,061

 
$
(1,388
)
 
$
453,673

Current liabilities
$
16,767

 
$
119

 
$
16,886

Deferred tax liability
46,713

 
(1,407
)
 
45,306

Other non-current liabilities
620

 
—

 
620

Total liabilities assumed
$
64,100

 
$
(1,288
)
 
$
62,812

          Net assets acquired
$
390,961

 
$
(100
)
 
$
390,861
Business Acquisition, Pro Forma Information
The provision for income taxes has also been adjusted for all periods, based upon the foregoing adjustments to historical results. The impact of adopting ASC 606 has been included based on an adoption date of January 1, 2018.
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2018
 
2017
 
2018
 
2017
Pro forma net sales
$
205,683

 
$
183,424

 
$
626,414

 
$
568,270

Pro forma income (loss) from continuing operations
$
(11,830
)
 
$
(8,436
)
 
$
(31,909
)
 
$
(52,840
)
Pro forma net income (loss)
$
(11,830
)
 
$
121,005

 
$
(31,909
)
 
$
87,355

Basic income (loss) from continuing operations per share
$
(0.41
)
 
$
(0.31
)
 
$
(1.15
)
 
$
(1.93
)
Diluted income (loss) from continuing operations per share
$
(0.41
)
 
$
(0.31
)
 
$
(1.15
)
 
$
(1.93
)